Edward H. Myles

Edward H. Myles, listed as finance chief, has filed trades across 3 companies (mainly through SEC (Form 4)), most often in Scholar Rock Holding Corp, AMAG Pharmaceuticals Inc. and Ocata Therapeutics, Inc. We count 34 filings; the first trade dates from 10 February 2016 and the latest from 10 March 2025.

Sales make up the whole of the open-market record (6 sales, €1.5M). The rest of the record consists of 22 share grants and 5 option exercises. Since January 2025: no purchases and 2 sales on the market.

Most recently, on 12 March 2025, the filings show an option exercise worth €276k in Scholar Rock Holding Corp. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.